Literature DB >> 19118554

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

Yuki Moritoki1, Weici Zhang, Koichi Tsuneyama, Katsunori Yoshida, Kanji Wakabayashi, Guo-Xiang Yang, Christopher Bowlus, William M Ridgway, Yoshiyuki Ueno, Aftab A Ansari, Ross L Coppel, Ian R Mackay, Richard A Flavell, M Eric Gershwin, Zhe-Xiong Lian.   

Abstract

BACKGROUND & AIMS: Mice that express a dominant-negative form of transforming growth factor-beta receptor restricted to T cells (dnTGF-betaRII) develop antimitochondrial antibodies and liver inflammation similar to human primary biliary cirrhosis.
METHODS: To address the role of B cells in this model of primary biliary cirrhosis, we bred B cell-deficient mice (Igmu(-/-)) with dnTGF-betaRII mice, creating Igmu(-/-)dnTGF-betaRII mice, and compared the resulting disease phenotype with that of dnTGF-betaRII mice (controls). We also performed adoptive transfer of dnTGF-betaRII CD8(+) splenocytes, with or without B cells, to 8-week-old female Rag-1(-/-) mice to assess the role of B cells in the inflammatory response.
RESULTS: The B cell-deficient Igmu(-/-)dnTGF-betaRII mice unexpectedly developed a more severe form of cholangitis than controls (dnTGF-betaRII mice) and had a significantly greater frequency of activated CD4(+) and CD8(+) T cells in the liver. They also had reduced frequency of Foxp3(+) regulatory T cells in the hepatic CD4(+) T-cell population and natural killer (NK) T cells (NK1.1(+) CD3(+)) in hepatic inflammatory cell infiltrates. The Igmu(-/-)dnTGF-betaRII mice had increased levels of proinflammatory cytokines (tumor necrosis factor-alpha and interleukin-6) and developed a more severe form of colitis than controls. Adoptive transfer of CD8(+) splenocytes from dnTGF-betaRII mice and peritoneal cavity-derived, but not spleen-derived, CD19(+) B cells into Rag-1(-/-) mice resulted in decreased amounts of liver inflammation and bile duct damage, compared with Rag-1(-/-) mice in which only CD8(+) splenocytes were transferred.
CONCLUSION: B cells have a suppressive effect on the inflammatory response in the dnTGF-betaRII model of primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118554     DOI: 10.1053/j.gastro.2008.11.035

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

3.  B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.

Authors:  Yuki Moritoki; Zhe-Xiong Lian; Keith Lindor; Joseph Tuscano; Koichi Tsuneyama; Weici Zhang; Yoshiyuki Ueno; Robert Dunn; Marilyn Kehry; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

4.  B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guérin vaccination against tuberculosis infection in mice.

Authors:  Tatiana K Kondratieva; Elvira I Rubakova; Irina A Linge; Vladimir V Evstifeev; Konstantin B Majorov; Alexander S Apt
Journal:  J Immunol       Date:  2009-12-18       Impact factor: 5.422

5.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

6.  Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

Authors:  Weici Zhang; Masanobu Tsuda; Guo-Xiang Yang; Koichi Tsuneyama; Guanghua Rong; William M Ridgway; Aftab A Ansari; Richard A Flavell; Ross L Coppel; Zhe-Xiong Lian; M Eric Gershwin
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

Review 7.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

8.  Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.

Authors:  Kazuhito Kawata; Guo-Xiang Yang; Yugo Ando; Hajime Tanaka; Weici Zhang; Yoshimasa Kobayashi; Koichi Tsuneyama; Patrick S C Leung; Zhe-Xiong Lian; William M Ridgway; Aftab A Ansari; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2013-07-24       Impact factor: 17.425

9.  Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.

Authors:  H Zhang; D B Stolz; G Chalasani; A W Thomson
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.